{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:39:32Z","timestamp":1774352372016,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11605-021-05042-w","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T13:03:31Z","timestamp":1623071011000},"page":"2411-2422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neoadjuvant Pelvic Radiotherapy in the Management of Rectal Cancer with Synchronous Liver Metastases: Is It Worth It?"],"prefix":"10.1016","volume":"25","author":[{"given":"Maitham A.","family":"Moslim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir L.","family":"Bastawrous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Rohan","family":"Jeyarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-021-05042-w_bb0010","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1007\/s11605-021-05042-w_bb0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gutjnl-2020-320625","article-title":"Colon and rectal cancer survival in seven high-income countries 2010\u20132014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)","volume":"70","author":"Araghi","year":"2021","journal-title":"Gut"},{"key":"10.1007\/s11605-021-05042-w_bb0020","doi-asserted-by":"crossref","unstructured":"Nieuwenhuizen S, Puijk RS, van den Bemd B, Aldrighetti L, Arntz M, van den Boezem PB, Bruynzeel AME, Burgmans MC, de Cobelli F, Coolsen MME, Dejong CHC, Derks S, Diederik A, van Duijvendijk P, Eker HH, Engelsman AF, Erdmann JI, F\u00fctterer JJ, Geboers B, Groot G, Haasbeek CJA, Janssen JJ, de Jong KP, Kater GM, Kazemier G, Kruimer JWH, Leclercq WKG, van der Leij C, Manusama ER, Meier MAJ, van der Meijs BB, Melenhorst M, Nielsen K, Nijkamp MW, Potters FH, Prevoo W, Rietema FJ, Ruarus AH, Ruiter SJS, Schouten EAC, Serafino GP, Sietses C, Swijnenburg RJ, Timmer FEF, Versteeg KS, Vink T, de Vries JJJ, de Wilt JHW, Zonderhuis BM, Scheffer HJ, van den Tol PMP, Meijerink MR. Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group. Cancers (Basel) 2020;12.","DOI":"10.3390\/cancers12071779"},{"key":"10.1007\/s11605-021-05042-w_bb0025","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1007\/s11605-021-05042-w_bb0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5005\/jp-journals-10018-1241","article-title":"Hepatic Metastasis from Colorectal Cancer","volume":"7","author":"Valderrama-Trevi\u00f1o","year":"2017","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"10.1007\/s11605-021-05042-w_bb0035","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12885-015-1683-1","article-title":"Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience","volume":"15","author":"Munro","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1007\/s11605-021-05042-w_bb0040","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ags3.12227","article-title":"Multidisciplinary approach of liver metastases from colorectal cancer","volume":"3","author":"Adam","year":"2019","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.21037\/jgo.2020.01.09","article-title":"Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm","volume":"11","author":"Jeyarajah","year":"2020","journal-title":"J Gastrointest Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0055","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.surg.2018.01.004","article-title":"Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?","volume":"163","author":"Creasy","year":"2018","journal-title":"Surgery"},{"key":"10.1007\/s11605-021-05042-w_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.soc.2020.08.009","article-title":"Debate: Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments","volume":"30","author":"Kawaguchi","year":"2021","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1007\/s11605-021-05042-w_bb0065","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/annonc\/mdp236","article-title":"A randomized phase III study comparing adjuvant 5-fluorouracil\/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer","volume":"20","author":"Ychou","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162400","article-title":"Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial","volume":"11","author":"Hasegawa","year":"2016","journal-title":"PLoS One"},{"key":"10.1007\/s11605-021-05042-w_bb0075","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1470-2045(19)30798-3","article-title":"Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial","volume":"21","author":"Bridgewater","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0080","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0085","first-page":"e361","article-title":"Comparative Oncologic Outcomes of Upper Third Rectal Cancers: A Meta-analysis","volume":"18","author":"Clancy","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"10.1007\/s11605-021-05042-w_bb0090","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/SLA.0b013e31820b8d52","article-title":"Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study","volume":"253","author":"Taylor","year":"2011","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1200\/JCO.2012.45.3258","article-title":"Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study","volume":"32","author":"Taylor","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0100","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(86)91510-2","article-title":"Recurrence and survival after total mesorectal excision for rectal cancer","volume":"1","author":"Heald","year":"1986","journal-title":"Lancet"},{"key":"10.1007\/s11605-021-05042-w_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918787993","article-title":"Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?","volume":"10","author":"Pfeiffer","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0110","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1200\/JCO.2005.08.144","article-title":"Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate","volume":"23","author":"Folkesson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0115","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1007\/s11605-021-05042-w_bb0120","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.prro.2020.08.004","article-title":"Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline","volume":"11","author":"Wo","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0130","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/DCR.0000000000001762","article-title":"The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer","volume":"63","author":"You","year":"2020","journal-title":"Dis Colon Rectum"},{"key":"10.1007\/s11605-021-05042-w_bb0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2016.04.010","article-title":"Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer","volume":"63","author":"Lutz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1007\/s11605-021-05042-w_bb0140","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1007\/s11605-021-05042-w_bb0145","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s10350-004-0713-x","article-title":"Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade","volume":"47","author":"Wheeler","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1007\/s11605-021-05042-w_bb0150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.radonc.2016.11.010","article-title":"Two countries - Two treatment strategies for rectal cancer","volume":"121","author":"Glimelius","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0155","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study","volume":"15","author":"Bosset","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0165","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0170","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0175","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"key":"10.1007\/s11605-021-05042-w_bb0180","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2019.03.016","article-title":"Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial","volume":"135","author":"Erlandsson","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0190","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br J Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00423-012-0940-x","article-title":"Erratum to: Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer-treatment results at 5 year follow-up","volume":"404","author":"Pach","year":"2019","journal-title":"Langenbecks Arch Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0200","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00423-011-0890-8","article-title":"Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up","volume":"397","author":"Pach","year":"2012","journal-title":"Langenbecks Arch Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0205","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0210","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/annonc\/mdv223","article-title":"Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial","volume":"26","author":"Fernandez-Martos","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0220","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1200\/JCO.2020.38.15_suppl.4007","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial","volume":"38","author":"Conroy","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0225","doi-asserted-by":"crossref","unstructured":"Fokas E, Allg\u00e4uer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Schmiegel W, Jacobasch L, Weitz J, Folprecht G, Schlenska-Lange A, Flentje M, Germer CT, Gr\u00fctzmann R, Schwarzbach M, Paolucci V, Bechstein WO, Friede T, Ghadimi M, Hofheinz RD, R\u00f6del C. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO\/ARO\/AIO-12. J Clin Oncol 2019;37:3212-3222.","DOI":"10.1200\/JCO.19.00308"},{"key":"10.1007\/s11605-021-05042-w_bb0230","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","article-title":"Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study","volume":"23","author":"Peeters","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0b013e3182196e1f","article-title":"Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial","volume":"254","author":"Garcia-Aguilar","year":"2011","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0240","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1463-1318.2005.00796.x","article-title":"Postoperative complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs chemoradiation","volume":"7","author":"Bujko","year":"2005","journal-title":"Colorectal Dis"},{"issue":"Suppl 3","key":"10.1007\/s11605-021-05042-w_bb0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1463-1318.2006.01066.x","article-title":"Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy","volume":"8","author":"Habr-Gama","year":"2006","journal-title":"Colorectal Dis"},{"key":"10.1007\/s11605-021-05042-w_bb0250","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis","volume":"2","author":"Dossa","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1007\/s11605-021-05042-w_bb0255","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.2013.51.7904","article-title":"Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial","volume":"32","author":"Schrag","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1740774518824539","article-title":"Challenges and solutions in the design and execution of the PROSPECT Phase II\/III neoadjuvant rectal cancer trial (NCCTG N1048\/Alliance)","volume":"16","author":"Schrag","year":"2019","journal-title":"Clin Trials"},{"key":"10.1007\/s11605-021-05042-w_bb0265","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2482-14-4","article-title":"Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer","volume":"14","author":"Naiken","year":"2014","journal-title":"BMC Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0270","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.prro.2015.11.014","article-title":"Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND\/UCLA Appropriateness Method","volume":"6","author":"Goodman","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0275","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0037-1598158","article-title":"The Role of Temporary Fecal Diversion","volume":"30","author":"Lightner","year":"2017","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0280","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1055\/s-0037-1606109","article-title":"The Perfect Total Mesorectal Excision Obviates the Need for Anything Else in the Management of Most Rectal Cancers","volume":"30","author":"Heald","year":"2017","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0285","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2017.12.014","article-title":"Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database","volume":"91","author":"van Rooijen","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1007\/s11605-021-05042-w_bb0290","doi-asserted-by":"crossref","unstructured":"Cho H, Kim JE, Kim KP, Yu CS, Kim JC, Kim JH, Lee MA, Jang HS, Oh ST, Kim SY, Oh JH, Kim DY, Hong YS, Kim TW. Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases. Am J Clin Oncol 2016;39:623-629.","DOI":"10.1097\/COC.0000000000000315"},{"key":"10.1007\/s11605-021-05042-w_bb0295","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/codi.13622","article-title":"Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival","volume":"19","author":"Labori","year":"2017","journal-title":"Colorectal Dis"},{"key":"10.1007\/s11605-021-05042-w_bb0300","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00384-016-2633-3","article-title":"Differences between colon and rectal cancer in complications, short-term survival and recurrences","volume":"31","author":"van der Sijp","year":"2016","journal-title":"Int J Colorectal Dis"},{"key":"10.1007\/s11605-021-05042-w_bb0305","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/DCR.0b013e318279b743","article-title":"Long-term results of the \"liver first\" approach in patients with locally advanced rectal cancer and synchronous liver metastases","volume":"56","author":"Ayez","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"10.1007\/s11605-021-05042-w_bb0310","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12094-017-1712-4","article-title":"Treatment strategies for rectal cancer with synchronous liver metastases: surgical and oncological outcomes with propensity-score analysis","volume":"20","author":"Salvador-Ros\u00e9s","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0315","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s12094-017-1818-8","article-title":"Oncological strategies for locally advanced rectal cancer with synchronous liver metastases, interval strategy versus rectum first strategy: a comparison of short-term outcomes","volume":"20","author":"Salvador-Ros\u00e9s","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0320","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.surg.2016.02.029","article-title":"Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer","volume":"160","author":"Silberhumer","year":"2016","journal-title":"Surgery"},{"key":"10.1007\/s11605-021-05042-w_bb0325","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/cncr.28467","article-title":"Patterns of care of radiation therapy in patients with stage IV rectal cancer: a Surveillance, Epidemiology, and End Results analysis of patients from 2004 to 2009","volume":"120","author":"Logan","year":"2014","journal-title":"Cancer"},{"key":"10.1007\/s11605-021-05042-w_bb0330","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.7150\/jca.28320","article-title":"Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study","volume":"10","author":"Luo","year":"2019","journal-title":"J Cancer"},{"key":"10.1007\/s11605-021-05042-w_bb0335","first-page":"e237","article-title":"Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis","volume":"18","author":"Renz","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"10.1007\/s11605-021-05042-w_bb0340","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00384-015-2272-0","article-title":"Comparison of oncologic outcomes of metastatic rectal cancer patients with or without neoadjuvant chemoradiotherapy","volume":"30","author":"Kim","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1007\/s11605-021-05042-w_bb0345","doi-asserted-by":"crossref","first-page":"650","DOI":"10.21037\/jgo.2017.06.07","article-title":"The role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis","volume":"8","author":"Fossum","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0350","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s11605-015-2861-9","article-title":"The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy","volume":"19","author":"Manyam","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0355","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jso.22109","article-title":"The effect of postoperative pelvic irradiation after complete resection of metastatic rectal cancer","volume":"105","author":"Chang","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0360","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1748-717X-5-75","article-title":"The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study","volume":"5","author":"Kim","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0365","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s11605-019-04256-3","article-title":"Planned Short-Course Radiation (scRT) is Superior to Upfront Concurrent Chemoradiation (CCRT) in Treating Metastatic Rectal Cancer","volume":"24","author":"Teng","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1007\/s11605-021-05042-w_bb0370","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1245\/s10434-017-5897-0","article-title":"Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study","volume":"24","author":"Bisschop","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0375","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1748-717X-6-99","article-title":"Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases","volume":"6","author":"Shin","year":"2011","journal-title":"Radiation Oncology"},{"key":"10.1007\/s11605-021-05042-w_bb0380","doi-asserted-by":"crossref","first-page":"990","DOI":"10.21037\/jgo.2017.09.02","article-title":"Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma","volume":"8","author":"Holliday","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0385","first-page":"414","article-title":"Outcomes of rectal cancer with liver oligometastases","volume":"5","author":"Resende Salgado","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0390","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13014-020-01574-8","article-title":"The effect of primary tumor radiotherapy in patients with Unresectable stage IV Rectal or Rectosigmoid Cancer: a propensity score matching analysis for survival","volume":"15","author":"Wang","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0395","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/0284186X.2013.837582","article-title":"Palliative pelvic radiotherapy of symptomatic incurable rectal cancer - a systematic review","volume":"53","author":"Cameron","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1007\/s11605-021-05042-w_bb0400","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00384-008-0456-6","article-title":"Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review","volume":"23","author":"Eisenberger","year":"2008","journal-title":"Int J Colorectal Dis"},{"key":"10.1007\/s11605-021-05042-w_bb0405","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1200\/JCO.2006.06.8353","article-title":"Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial","volume":"24","author":"Portier","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-021-05042-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11605-021-05042-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23012453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23012453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-021-05042-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:04:51Z","timestamp":1761077091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23012453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":80,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1091255X23012453"],"URL":"https:\/\/doi.org\/10.1007\/s11605-021-05042-w","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant Pelvic Radiotherapy in the Management of Rectal Cancer with Synchronous Liver Metastases: Is It Worth It?","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-021-05042-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}